Literature DB >> 3128789

Genetically engineered immunoglobulins reveal structural features controlling segmental flexibility.

W P Schneider1, T G Wensel, L Stryer, V T Oi.   

Abstract

We have carried out nanosecond fluorescence polarization studies of genetically engineered immunoglobulins to determine the structural features controlling their segmental flexibility. The proteins studied were hybrids of a relatively rigid isotype (mouse IgG1) and a relatively flexible one (mouse IgG2a). They have identical light chains and heavy chain variable regions and have the same combining sites for epsilon-dansyl-L-lysine, a fluorescent hapten. The fluorescence of the bound dansyl chromophore was excited at 348 nm with subnanosecond laser pulses, and the emission in the nanosecond time range was measured with a single-photon-counting apparatus. The emission anisotropy kinetics of the hybrid antibodies revealed that segmental flexibility is controlled by the heavy chain constant region 1 (CH1) as well as by the hinge. In contrast, the CH2 and CH3 domains did not influence segmental flexibility. The hinge and CH1 domains must be properly matched to allow facile movement of the Fab units. Studies of hybrids of IgG1 and IgG2a within CH1 showed that the loop formed by residues 131-139 is important in controlling segmental flexibility. X-ray crystallographic studies by others of human IgG1 have shown that this loop makes several van der Waals contacts with the hinge.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128789      PMCID: PMC280026          DOI: 10.1073/pnas.85.8.2509

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses.

Authors:  N McCloskey; M W Turner; P Steffner; R Owens; D Goldblatt
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.

Authors:  L K Tan; R J Shopes; V T Oi; S L Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?

Authors:  O Pritsch; G Hudry-Clergeon; M Buckle; Y Petillot; J P Bouvet; J Gagnon; G Dighiero
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

4.  A human immunoglobulin IGHG3 allele (Gmb0,b1,c3,c5,u) with an IGHG4 converted region and three hinge exons.

Authors:  S Huck; G Lefranc; M P Lefranc
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen.

Authors:  Ivan Correia; Joyce Sung; Randall Burton; Clarissa G Jakob; Bridget Carragher; Tariq Ghayur; Czeslaw Radziejewski
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

6.  Disulfide scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations.

Authors:  Xiaoling Wang; Sandeep Kumar; Satish K Singh
Journal:  Pharm Res       Date:  2011-06-14       Impact factor: 4.200

7.  Virulence genes promote conjugative transfer of the Ti plasmid between Agrobacterium strains.

Authors:  T R Steck; C I Kado
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

Review 8.  Biophysical characterization of dynamic structures of immunoglobulin G.

Authors:  Saeko Yanaka; Rina Yogo; Koichi Kato
Journal:  Biophys Rev       Date:  2020-05-15

Review 9.  Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction.

Authors:  N S Greenspan; L J Cooper
Journal:  Springer Semin Immunopathol       Date:  1993

10.  Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse.

Authors:  Ruben J Boado; Yun Zhang; Yuntao Wang; William M Pardridge
Journal:  Biotechnol Bioeng       Date:  2009-03-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.